Genmab reported DKK5.43 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q2 Jun/2025 34.31 26.44 21.70 Aug/07
FY2025Q1 Mar/2025 20.19 16.27 20.18 May/08
FY2024Q4 Dec/2024 59.49 24.90 9.66 Feb/12
FY2024Q3 Sep/2024 19.94 21.70 32.46 Nov/06
FY2024Q2 Jun/2024 21.70 21.35 20.61 Aug/08




Eps Change Date
Agios Pharmaceuticals USD -1.09 0.6 Sep/2026
Almirall EUR 0.2 0.13 Jun/2026
Amarin USD 0.14 0.06 Dec/2025
Amgen USD 6.45 0.16 Sep/2026
argenx SE USD 7.8 1.36 Sep/2026
AstraZeneca USD 2.79 0.16 Sep/2026
Bayer EUR 0.31 0.64 Sep/2026
BioMarin Pharmaceutical USD 0.23 0.97 Sep/2026
Demant DKK 6.3 0.2 Jun/2026
Exelixis USD 0.94 0.03 Sep/2026
Fresenius Medical Care EUR 1.11 0.01 Sep/2026
Genmab DKK 5.43 4.6 Jun/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
GN Store Nord DKK 1.99 3.47 Sep/2026
GRIFOLS EUR 0.3 0.07 Sep/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Insmed USD -0.46 0.4 Sep/2026
Lakefront Biotherapeutics EUR -0.23 0.03 Sep/2026
Lonza CHF 6.07 1.92 Jun/2025
Merck EUR 2.04 2.58 Sep/2026
Novartis USD 2.46 0.05 Sep/2026
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 3.55 1.46 Sep/2026
UCB EUR 5.65 3.21 Dec/2025